| Literature DB >> 30693079 |
S K Schäfer1, N Becker2, L King3, A Horsch4,5, T Michael1.
Abstract
Background: Antonovsky's concept of sense of coherence (SOC) - as a global orientation reflecting an individual's feeling of confidence in both the predictability of their internal and external environment and their ability to cope with stressful and challenging situations in life - shows a negative association with symptoms of post-traumatic stress. However, single studies varying in study characteristics provide heterogeneous effect size estimations. Objective: The purpose of the current study is to investigate the relationship between SOC and post-traumatic stress disorder (PTSD) symptom severity for the first time on a meta-analytical level. Method: The random-effects meta-analysis is based on zero-order correlations (r) and consists of 47 independent samples out of 45 studies (N = 10,883).Entities:
Keywords: PTSD; PTSD symptoms; Sense of coherence; meta-analysis; post-traumatic stress disorder; resilience; review; salutogenesis; • This meta-analysis reports a robust correlation between sense of coherence (SOC) and post-traumatic stress disorder (PTSD) symptoms. • Higher SOC levels are linked to lower PTSD symptom scores. • No significant moderating effects were found for the correlation between SOC and PTSD symptoms. • There were homogeneous correlations for Holocaust and war traumas and enduring stressors. • Future research needs to investigate a potential causal relationship.
Year: 2019 PMID: 30693079 PMCID: PMC6338278 DOI: 10.1080/20008198.2018.1562839
Source DB: PubMed Journal: Eur J Psychotraumatol ISSN: 2000-8066
Figure 1.Schematic illustration of the theoretical framework concerning the relationship between sense of coherence and health outcomes, especially post-traumatic stress disorder (PTSD) symptom severity.
Figure 2.Search terms and search engines, as well as hits per included database.
Figure 3.Flowchart of the study selection process, adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) group (Moher et al., 2009).
Included samples and their characteristics.
| Sample | Country | Age (years) | Female (%) | Criterion A | Trauma type | Acute vs chronic | |||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Arévalo, Prado, and Amaro (2008) | USA | 393 | −.22 | 33.70 | 100 | 2 | ||
| 2 | Cassel and Suedfeld (2006) | Canada | 45 | −.52 | 62 | 2 | WT | Chronic | |
| 4 | Dudek and Szymczak (2011) | Poland | 453 | −.47 | 28.50 | 0 | 1 | PT | |
| 5 | Dudek and Szymczak (2011) | Poland | 821 | −.35 | 33.50 | 0 | 1 | PT | |
| 3 | Dudek and Koniarek (2000) | Poland | 378 | −.27 | 34.00 | 0 | 2 | PT | |
| 6 | Ekblad and Wennström (1997) | Sweden | 33 | −.53 | 39.00 | 61 | 2 | WT | Chronic |
| 7 | Engelhard et al. ( | Netherlands | 117 | −.25 | 31.00 | 100 | 3 | MT | Acute |
| 8 | Ferrajão and Oliveira ( | Portugal | 120 | −.85 | 64.00 | 0 | 2 | WT | Chronic |
| 9 | Forstmeier et al. ( | Germany | 103 | −.30 | 78.78 | 1 | 2 | WT | Chronic |
| 10 | François, Brouette, Etienne, and Fontaine (2000) | France | 14 | −.59 | 40.28 | 50 | 1 | ||
| 11 | Frommberger et al. (1999) | Germany | 51 | −.56 | 33.60 | 33 | 1 | AT | Acute |
| 12 | Glück et al. ( | Austria | 91 | −.58 | 73.60 | 68 | 2 | WT | Chronic |
| 13 | Hepp, Moergeli, Büchi, Wittmann, and Schnyder (2005) | Switzerland | 101 | −.34 | 37.90 | 26 | 1 | AT | Acute |
| 14 | Hollifield, Warner, Krakow, Jenkins, and Westermeyer (2009) | USA | 252 | −.42 | 44.00 | 46 | 2 | WT | Chronic |
| 15 | Hyun Ju (2017) | Korea | 162 | −.39 | 93 | 2 | PT | ||
| 16 | Jonsson, Segesten, and Mattsson (2003) | Sweden | 223 | −.35 | 38.36 | 21 | 2 | PT | |
| 17 | Kaiser, Sattler, Bellack, and Dersin (1996) | USA | 193 | −.24 | 19.54 | 64 | 1 | Acute | |
| 18 | Kassen and DiLalla (2008) | 51 | −.44 | 33.50 | 43 | 2 | PT | ||
| 19 | Kazlauskas et al. ( | Lithuania | 110 | −.36 | 44.65 | 68 | 2 | ||
| 20 | Kaźmierczak, Strelau, and Zawadzki (2016) | Poland | 289 | −.39 | 44.00 | 34 | 1 | AT | Acute |
| 21 | Kindermann et al. (2017) | Germany | 64 | −.53 | 37.00 | 56 | 2 | PT | |
| 22 | Scheffer Lindgren and Renck (2008) | Sweden | 14 | −.52 | 38.00 | 100 | 1 | Chronic | |
| 23 | Livneh and Martz (2014)* | USA | 95 | −.71 | 47.50 | 30 | 2 | ||
| 24 | Mehnert et al. ( | Germany | 71 | −.18 | 48.00 | 0 | 1 | PT | Acute |
| 25 | Nielsen, Matthiesen, and Einarsen (2008) | Norway | 221 | −.41 | 50.47 | 63 | 3 | Chronic | |
| 26 | Nishi et al. ( | Japan | 118 | −.47 | 39.70 | 28.00 | 1 | AT | Acute |
| 27 | Noyman-Veksler, Herishanu-Gilutz, Kofman, Holchberg, and Shahar (2015) | Israel | 92 | −.44 | 28.70 | 100 | 3 | MT | Acute |
| 28 | Pham, Vinck, Kinkodi, and Weinstein (2010)* | Congo | 2466 | −.66 | 37.00 | 50 | 2 | WT | Chronic |
| 29 | Ratzer, Brink, Knudsen, and Elklit (2014) | Denmark | 43 | −.36 | 40.40 | 42 | 1 | MT | |
| 30 | Römisch, Leban, Habermas, and Döll-Hentschker (2014) | Germany | 14 | −.15 | 32.00 | 100 | 1 | ||
| 32 | Schnyder, Büchi, Mörgeli, Sensky, and Klaghofer (1999) | Switzerland | 112 | −.35 | 37.90 | 26 | 1 | AT | Acute |
| 31 | Schnyder, Wittmann, Friedrich-Perez, Hepp, and Moergeli (2008) | Switzerland | 241 | −.24 | 41.40 | 33 | 2 | AT | Acute |
| 33 | Sommer and Ehlert (2004) | Switzerland | 519 | −.18 | 44.04 | 2.00 | 2 | AT | Acute |
| 34 | Steinlin et al. (2017) | Switzerland | 235 | −.37 | 38.60 | 61 | 2 | PT | |
| 35 | Stramrood et al. (2011) | Netherlands | 428 | −.59 | 32.00 | 100 | 3 | MT | Acute |
| 36 | Streb et al. ( | Switzerland/Lichtenstein | 625 | −.44 | 36.60 | 31 | 2 | PT | |
| 38 | Tagay, Erim, Brähler, and Senf (2006) | Germany | 389 | −.54 | 35.50 | 68.30 | |||
| 37 | Tagay, Schlottbohm, Reyes-Rodriguez, Repic, and Senf (2014) | Germany | 103 | −.24 | 29.11 | 100 | 2 | ||
| 39 | Teegen and Handwerk (2006) | Germany | 59 | −.54 | 82.00 | 100 | 2 | WT | Chronic |
| 40 | Tham, Christensson, and Lena Ryding (2007) | Sweden | 75 | −.29 | 32.70 | 100 | 3 | MT | Acute |
| 41 | van der Hal-van Raalte, van IJzendoorn, and Bakermans–Kranenburg (2008) | Israel | 203 | −.43 | 64.60 | 63 | 2 | WT | Chronic |
| 44 | Veronese, Fiore, Castiglioni, el Kawaja, and Said (2012) | Israel | 114 | −.24 | 29.85 | 66 | 2 | PT | |
| 43 | Veronese and Pepe ( | Israel | 216 | −.15 | 30.37 | 44 | 2 | PT | |
| 42 | Veronese and Pepe (2017) | Israel | 159 | −.28 | 29.13 | 47 | 2 | PT | |
| 45 | Wettergren, Langius, Bjorkholm, and Bjorvell (1999) | Sweden | 15 | −.22 | 37.00 | 40.00 | 1 | MT | Chronic |
| 46 | Zerach and Levin (2018) | Israel | 102 | −.21 | 43.59 | 0 | 2 | PT | |
| 47 | Zerach and Levin (2018) | 90 | −.60 | 36.28 | 0 | 2 | PT |
* Samples excluded as outliers.
See Appendix A, Table A1, for a detailed version of the table including all moderator variables. n, sample size; r, reported bivariate correlation or mean of reported correlations; Criterion A: 1 = criterion A was ensured on an individual basis; 2 = criterion A was not ensured on an individual basis but was probably met (i.e. high-risk samples); 3 = events did not fulfil stringent criterion A; Trauma type: AT, accidental trauma; MT, medical trauma; PT, professional trauma; WT, Holocaust and war trauma.
Included samples and their characteristics.
| Sample | Country | Age (years) | Female (%) | SOC measure | PTSD measure | Criterion A | Trauma type | Acute vs chronic | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Arévalo, Prado, and Amaro (2008) | USA | 393 | −.22 | 33.70 | 100 | SOC-13 | PDS | 2 | ||
| 2 | Cassel and Suedfeld (2006) | Canada | 45 | −.52 | 62 | SOC-13 | Trauma Symptom Checklist | 2 | WT | Chronic | |
| 4 | Dudek and Szymczak (2011) | Poland | 453 | −.47 | 28.50 | 0 | SOC-27 | K-PTSD | 1 | PT | |
| 5 | Dudek and Szymczak (2011) | Poland | 821 | −.35 | 33.50 | 0 | SOC-27 | K-PTSD | 1 | PT | |
| 3 | Dudek and Koniarek (2000) | Poland | 378 | −.27 | 34.00 | 0 | SOC-29 | PTSD-I | 2 | PT | |
| 6 | Ekblad and Wennström (1997) | Sweden | 33 | −.53 | 39.00 | 61 | SOC-29 (M) | SCID assessment | 2 | WT | Chronic |
| 7 | Engelhard et al. ( | Netherlands | 117 | −.25 | 31.00 | 100 | SOC-13 | PSS-SR | 3 | MT | Acute |
| 8 | Ferrajão and Oliveira ( | Portugal | 120 | −.85 | 64.00 | 0 | SOC-29 | IES-R | 2 | WT | Chronic |
| 9 | Forstmeier et al. ( | Germany | 103 | −.30 | 78.78 | 1 | SOC-29 | PDS | 2 | WT | Chronic |
| 10 | François, Brouette, Etienne, and Fontaine (2000) | France | 14 | −.59 | 40.28 | 50 | SOC-29 | IES | 1 | ||
| 11 | Frommberger et al. (1999) | Germany | 51 | −.56 | 33.60 | 33 | SOC-29 | IES, PSS | 1 | AT | Acute |
| 12 | Glück et al. ( | Austria | 91 | −.58 | 73.60 | 68 | SOC-13 | ETI | 2 | WT | Chronic |
| 13 | Hepp, Moergeli, Büchi, Wittmann, and Schnyder (2005) | Switzerland | 101 | −.34 | 37.90 | 26 | SOC-29 | CAPS-2 | 1 | AT | Acute |
| 14 | Hollifield, Warner, Krakow, Jenkins, and Westermeyer (2009) | USA | 252 | −.42 | 44.00 | 46 | SOC-13 | NMRSCL-121 (PTSD) | 2 | WT | Chronic |
| 15 | Hyun Ju (2017) | Korea | 162 | −.39 | 93 | SOC-29 | IES-R | 2 | PT | ||
| 16 | Jonsson, Segesten, and Mattsson (2003) | Sweden | 223 | −.35 | 38.36 | 21 | SOC-13 | IES, PTSS-10 | 2 | PT | |
| 17 | Kaiser, Sattler, Bellack, and Dersin (1996) | USA | 193 | −.24 | 19.54 | 64 | SOC-29 | Questionnaire based on DSM III criteria | 1 | Acute | |
| 18 | Kassen and DiLalla (2008) | 51 | −.44 | 33.50 | 43 | SOC-29 | IES-R, PSS | 2 | PT | ||
| 19 | Kazlauskas et al. ( | Lithuania | 110 | −.36 | 44.65 | 68 | SOC-13 | IES-R | 2 | ||
| 20 | Kaźmierczak, Strelau, and Zawadzki (2016) | Poland | 289 | −.39 | 44.00 | 34 | – | PTSD Factorial Version Inventory | 1 | AT | Acute |
| 21 | Kindermann et al. (2017) | Germany | 64 | −.53 | 37.00 | 56 | SOC-29 | QST | 2 | PT | |
| 22 | Scheffer Lindgren and Renck (2008) | Sweden | 14 | −.52 | 38.00 | 100 | SOC-13 | IES-R | 1 | Chronic | |
| 23 | Livneh and Martz (2014)* | USA | 95 | −.71 | 47.50 | 30 | SOC-29 | PPTSD-R | 2 | ||
| 24 | Mehnert, Nanninga, Fauth, and Schäfer ( | Germany | 71 | −.18 | 48.00 | 0 | LAP-R | PDS | 1 | PT | Acute |
| 25 | Nielsen, Matthiesen, and Einarsen (2008) | Norway | 221 | −.41 | 50.47 | 63 | SOC-29 | IES-R | 3 | Chronic | |
| 26 | Nishi et al. ( | Japan | 118 | −.47 | 39.70 | 28.00 | SOC-29 | IES-R | 1 | AT | Acute |
| 27 | Noyman-Veksler, Herishanu-Gilutz, Kofman, Holchberg, and Shahar (2015) | Israel | 92 | −.44 | 28.70 | 100 | SOC-13 | PDS | 3 | MT | Acute |
| 28 | Pham, Vinck, Kinkodi, and Weinstein (2010)* | Congo | 2466 | −.66 | 37.00 | 50 | SOC-13 | PCL-C | 2 | WT | Chronic |
| 29 | Ratzer, Brink, Knudsen, and Elklit (2014) | Denmark | 43 | −.36 | 40.40 | 42 | SOC-29 | HTQ | 1 | MT | |
| 30 | Römisch, Leban, Habermas, and Döll-Hentschker (2014) | Germany | 14 | −.15 | 32.00 | 100 | SOC-L9 (?) | PDS | 1 | ||
| 32 | Schnyder, Büchi, Mörgeli, Sensky, and Klaghofer (1999) | Switzerland | 112 | −.35 | 37.90 | 26 | SOC-29 | CAPS-2, IES-R | 1 | AT | Acute |
| 31 | Schnyder, Wittmann, Friedrich-Perez, Hepp, and Moergeli (2008) | Switzerland | 241 | −.24 | 41.40 | 33 | CAPS-2 | 2 | AT | Acute | |
| 33 | Sommer and Ehlert (2004) | Switzerland | 519 | −.18 | 44.04 | 2.00 | SOC-29 | PDS | 2 | AT | Acute |
| 34 | Steinlin et al. (2017) | Switzerland | 235 | −.37 | 38.60 | 61 | SOC-L9 (?) | IES-R, STS | 2 | PT | |
| 35 | Stramrood et al. (2011) | Netherlands | 428 | −.59 | 32.00 | 100 | SOC-13 | TES-B | 3 | MT | Acute |
| 36 | Streb et al. ( | Switzerland and Lichtenstein | 625 | −.44 | 36.60 | 31 | SOC-L9 | PDS | 2 | PT | |
| 38 | Tagay, Erim, Brähler, and Senf (2006) | Germany | 389 | −.54 | 35.50 | 68.30 | SOC-13 | IES-R, (PDS) | |||
| 37 | Tagay, Schlottbohm, Reyes-Rodriguez, Repic, and Senf (2014) | Germany | 103 | −.24 | 29.11 | 100 | SOC-13 | ETI | 2 | ||
| 39 | Teegen and Handwerk (2006) | Germany | 59 | −.54 | 82.00 | 100 | SOC-13 | PCL-C | 2 | WT | Chronic |
| 40 | Tham, Christensson, and Lena Ryding (2007) | Sweden | 75 | −.29 | 32.70 | 100 | SOC-13 | IES-R | 3 | MT | Acute |
| 41 | van der Hal-van Raalte, van IJzendoorn, Bakermans-Kranenburg, and others (2008) | Israel | 203 | −.43 | 64.60 | 63 | SOC-13 | PDS | 2 | WT | Chronic |
| 44 | Veronese, Fiore, Castiglioni, el Kawaja, and Said (2012) | Israel | 114 | −.24 | 29.85 | 66 | SOC-29 | IES-R | 2 | PT | |
| 43 | Veronese and Pepe ( | Israel | 216 | −.15 | 30.37 | 44 | SOC-29 | IES-R | 2 | PT | |
| 42 | Veronese and Pepe (2017) | Israel | 159 | −.28 | 29.13 | 47 | SOC-29 | IES-R-13 | 2 | PT | |
| 45 | Wettergren, Langius, Bjorkholm, and Bjorvell (1999) | Sweden | 15 | −.22 | 37.00 | 40.00 | SOC-13 | IES-R | 1 | MT | Chronic |
| 46 | Zerach and Levin (2018) | Israel | 102 | −.21 | 43.59 | 0 | SOC-13 | PTSS | 2 | PT | |
| 47 | Zerach and Levin (2018) | 90 | −.60 | 36.28 | 0 | SOC-13 | PTSS | 2 | PT |
* Samples excluded as outliers.
n, sample size; r, reported bivariate correlation or mean of reported correlations; SOC, sense of coherence; PTSD, post-traumatic stress disorder; Criterion A: 1 = criterion A was ensured on an individual basis; 2 = criterion A was not ensured on an individual basis but was probably met (i.e. high-risk samples); 3 = events did not fulfil stringent criterion A; Trauma type: AT, accidental trauma; MT, medical trauma; PT, professional trauma; WT, Holocaust and war trauma.
Inventories: Sense of coherence: SOC-29, Sense of Coherence Scale – 29-item version; SOC-29 (M), Sense of Coherence Scale – 29-item version, meaningfulness scale; SOC-13, Sense of Coherence Scale – 13-item version; SOC-L9, Sense of Coherence Scale – 9-item version; LAP-R, Life Attitude Profile – Revised; PTSD: CAPS-2, Clinician-Administered PTSD Scales; ETI, Essener Trauma Inventar; HTQ, Harvard Trauma Questionnaire; IES(-R), Impact of Event Scale (Revised); K-PTSD, PTSD self-rating measure based on DSM-TR criteria; NMRSCL-121 (PTSD), New Mexico Refugee Symptom Checklist-121; PCL-C, PTSD Checklist – Civilian version; PDS, Posttraumatic Stress Diagnostic Scale; PPTSD-R, Purdue Posttraumatic Stress Disorder – Revised; PSS-SR, PTSD Symptom Scale – Self Report; PTSD-I, PTSD Interview; PTSS-10, Post-Traumatic Symptom Scale; QST, Questionnaire for Secondary Traumatization; SCID, Structured Clinical Interview for DSM-III-R; TES-B, Traumatic Event Scale-B.
Figure 4.Forest plot of the meta-analysis including all samples.
Results of the main analyses and nominally scaled moderator variables.
| Analysis | 95% CIu | 95% CIl | df | ||||||
|---|---|---|---|---|---|---|---|---|---|
| All studies | 47 | −.41 | .02 | −.36 | −.46 | 695.52 | 46 | < .001 | 89.35 |
| −.53 | .04 | −.40 | −.66 | ||||||
| Without outliers | 43 | −.39 | .01 | −.35 | −.43 | 172.56 | 42 | < .001 | 72.56 |
| −.40 | .01 | −.35 | −.45 | ||||||
| SOC-13 | 18 | −.42 | .02 | −.35 | −.49 | 81.51 | 17 | < .001 | 77.18 |
| −.46 | .02 | −.36 | −.56 | ||||||
| SOC-29 | 16 | −.35 | .01 | −.29 | −.41 | 37.66 | 15 | .001 | 58.08 |
| −.33 | .01 | −.25 | −.40 | ||||||
| IES(-R) | 11 | −.40 | .01 | −.33 | −.47 | 22.61 | 10 | .012 | 52.44 |
| −.44 | .01 | −.33 | −.54 | ||||||
| PDS | 8 | −.32 | .01 | −.22 | −.41 | 35.94 | 7 | < .001 | 76.70 |
| −.33 | .01 | −.17 | −.50 | ||||||
| Other measures | 19 | −.41 | .01 | −.34 | −.47 | 103.07 | 18 | < .001 | 80.11 |
| −.42 | .01 | −.34 | −.51 | ||||||
| Ensured on individual basis | 14 | −.39 | .00 | −.33 | −.44 | 22.06 | 13 | .055 | 43.49 |
| −.39 | .00 | −.31 | −.47 | ||||||
| High-risk samples | 23 | −.37 | .01 | −.32 | .43 | 85.95 | 22 | < .001 | 73.97 |
| −.36 | .01 | −.30 | −.43 | ||||||
| Stressful life events not fulfilling criterion A | 5 | −.42 | .02 | −.29 | −.54 | 22.84 | 4 | < .001 | 78.76 |
| −.50 | .02 | −.22 | −.78 | ||||||
| Accidental traumas (e.g. traffic accidents) | 7 | −.35 | .01 | −.25 | −.45 | 25.11 | 6 | < .001 | 74.35 |
| −.32 | .01 | −.17 | −.46 | ||||||
| Professional traumas | 14 | −.38 | .01 | −.32 | −.44 | 40.40 | 13 | < .001 | 71.72 |
| −.39 | .01 | −.32 | −.46 | ||||||
| Medical traumas | 6 | −.40 | .02 | −.26 | −.53 | 21.91 | 5 | < .001 | 69.82 |
| −.52 | .02 | −.17 | −.86 | ||||||
| Holocaust and war traumas | 7 | −.47 | .00 | −.40 | −.54 | 8.32 | 6 | .215 | 29.38 |
| −.46 | .00 | −.39 | −.54 | ||||||
| Short | 13 | −.35 | .02 | −.27 | −.43 | 86.94 | 12 | < .001 | 78.77 |
| −.39 | .03 | −.25 | −.53 | ||||||
| Long | 9 | −.45 | .00 | −.40 | −.51 | 9.59 | 8 | .295 | 14.70 |
| −.45 | .00 | −.39 | −.51 |
All results of moderator analyses exclude the outliers and are based on 43 samples. The second line of each analysis reports results corrected for small sample effects according to Henmi and Copas (2010). All results including outlying studies are presented in Appendix C, Table C1.
k, number of samples; M(r), mean correlation; τ2, estimated variance in population; CIl, lower bound of 95% confidence interval; CIu, upper bound of 95% confidence interval; Q, Q statistic; df, degrees of freedom of Q statistic; p, significance of Q; I2, index of heterogeneity; SOC, sense of coherence; PTSD, post-traumatic stress disorder; IES(-R), Impact of Event Scale (Revised); PDS, Post-traumatic Stress Diagnostic Scale; DSM, Diagnostic and Statistical Manual of Mental Disorders.
Results of the main analyses and nominally scaled moderator variables (outliers included).
| Analysis | 95% CIu | 95% CIl | df | ||||||
|---|---|---|---|---|---|---|---|---|---|
| All studies | 47 | −.41 | .02 | −.36 | −.46 | 695.52 | 46 | < .001 | 89.35 |
| −.53 | .04 | −.40 | −.66 | ||||||
| Without outliers | 43 | −.39 | .01 | −.35 | −.43 | 172.56 | 42 | < .001 | 72.56 |
| −.40 | .01 | −.35 | −.45 | ||||||
| SOC-13 | 19 | −.44 | .02 | −.37 | −.51 | 195.24 | 18 | < .001 | 87.57 |
| −.59 | .02 | −.41 | −.76 | ||||||
| SOC-29 | 19 | −.40 | .03 | −.31 | −.49 | 365.25 | 18 | < .001 | 89.05 |
| −.51 | .08 | −.30 | −.71 | ||||||
| IES(-R) | 13 | −.42 | .03 | −.30 | −.53 | 221.73 | 12 | < .001 | 89.59 |
| −.59 | .07 | −.31 | −.86 | ||||||
| PDS | 8 | −.32 | .01 | −.22 | −.41 | 35.94 | 7 | < .001 | 76.70 |
| −.33 | .01 | −.17 | −.50 | ||||||
| Other measures | 21 | −.44 | .02 | −.37 | −.51 | 287.86 | 20 | < .001 | 90.74 |
| −.56 | .03 | −.39 | −.73 | ||||||
| Ensured on individual basis | 14 | −.39 | .00 | −.33 | −.44 | 22.06 | 13 | .055 | 43.49 |
| −.39 | .00 | −.31 | −.47 | ||||||
| High-risk samples | 27 | −.41 | .03 | −.34 | −.48 | 569.15 | 26 | < .001 | 92.99 |
| −.56 | .05 | −.37 | −.76 | ||||||
| Stressful life events not fulfilling criterion A | 5 | −.42 | .02 | −.29 | −.54 | 22.84 | 4 | < .001 | 78.76 |
| −.51 | .02 | −.23 | −.78 | ||||||
| Accidental traumas (e.g. traffic accidents) | 7 | −.35 | .01 | −.25 | −.45 | 25.11 | 6 | < .001 | 74.35 |
| −.31 | .06 | −.17 | −.45 | ||||||
| Professional traumas | 15 | −.36 | .01 | −.30 | −.42 | 52.57 | 14 | < .001 | 77.59 |
| −.38 | .01 | −.30 | −.46 | ||||||
| Medical traumas | 6 | −.40 | .02 | −.26 | −.53 | 21.91 | 5 | < .001 | 69.82 |
| −.52 | .02 | −.17 | −.86 | ||||||
| Holocaust and war traumas | 9 | −.55 | .02 | −.44 | −.66 | 114.01 | 8 | < .001 | 93.35 |
| −.66 | .02 | −.34 | −.99 | ||||||
| Short | 13 | −.35 | .02 | −.27 | −.43 | 86.94 | 12 | < .001 | 78.77 |
| −.39 | .03 | −.25 | −.53 | ||||||
| Long | 11 | −.53 | .02 | −.42 | −.63 | 136.11 | 10 | < .001 | 92.33 |
| −.66 | .02 | −.37 | −.94 |
All results of moderator analyses exclude the outliers and are based on 47 samples. The second line of each analysis reports results corrected for small sample effects according to Henmi and Copas (2010). k, number of samples; M(r), mean correlation; τ2, estimated variance in population; CIl, lower bound of 95% confidence interval; CIu, upper bound of 95% confidence interval; Q, Q statistic; df, degrees of freedom of Q statistic; p, significance of Q; I2, index of heterogeneity; SOC, sense of coherence; PTSD, post-traumatic stress disorder; IES(-R), Impact of Event Scale (Revised); PDS, Post-traumatic Stress Diagnostic Scale.
Results for the interval scaled moderator variables (outliers included).
| Analysis | df | df | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Publication year | 47 | .02 | 1.37 | 1 | .242 | 5.68 | 612.85 | 45 | < .001 | 88.72 |
| Percentage of females (%) | 47 | .02 | .00 | 1 | .93 | .07 | 695.38 | 45 | < .001 | 89.06 |
| Age | 45 | .02 | 5.73 | 1 | .017 | 14.21 | 611.84 | 43 | < .001 | 88.09 |
All results of moderator analyses including the outliers are based on 47 samples.
k, number of samples; τ2, estimated variance in population; QM, Q statistic of the moderating variable; df, degrees of freedom of Q statistic; Q, Q statistic of a main analysis relying on the included samples; p, significance of QM and Q; I2, index of heterogeneity.
Figure 5.Results of the influence statistics as the basis for outlier identification. The outliers identified by the influence analyses are marked by a circle. Study numbers correspond to those in the forest plot.
Results for the interval scaled moderator variables.
| Analysis | df | df | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Publication year | 43 | .01 | .84 | 1 | .358 | 6.28 | 160.34 | 41 | < .001 | 71.10 |
| Percentage of females (%) | 43 | .01 | 1.22 | 1 | .270 | 4.76 | 156.14 | 41 | < .001 | 70.88 |
| Age | 41 | .01 | 2.12 | 1 | .145 | 5.57 | 170.34 | 39 | < .001 | 72.58 |
All results of moderator analyses exclude the outliers and are based on 33 samples. Results including outlying studies are presented as Appendix C, Table C2.
k, number of samples; τ2, estimated variance in population; QM, Q statistic of the moderating variable; df, degrees of freedom of Q statistic; Q, Q statistic of a main analysis relying on the included samples; p, significance of QM and Q; I2, index of heterogeneity.
Figure C1.Moderating effect of age on the relationship between sense of coherence and post-traumatic stress disorder (PTSD) symptoms. Smaller dots indicate larger standard errors, i.e. more precise findings are shown as larger dots.
Pearson correlations of the moderator variables (outliers excluded).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Publication year | |||||||
| 2 | Percentage of females (%) | .08 | ||||||
| 3 | Age | .10 | −.08 | |||||
| 4 | SOC scale version [SOC-13 (1) vs SOC-29 (2)] | −.21 | −.40* | −.13 | ||||
| 5 | PTSD measure [IES (1) vs PDS (2)] | .13 | .32 | .32 | −.14 | |||
| 6 | Trauma criterion A [stringent criteria (1) vs high-risk samples (2)] | .27 | .13 | .29 | −.31 | .22 | ||
| 7 | Duration of stressor [short (1) vs long (2)] | −.01 | .07 | .67** | −.27 | −.10 | .65** |
The diagonal contains the number of studies (k) included in each moderator analysis.
SOC, sense of coherence; PTSD, post-traumatic stress disorder; IES, Impact of Event Scale; PDS, Post-traumatic Stress Diagnostic Scale
*p < .05, **p < .01.
Figure 6.Trim-and-fill funnel plot of the main analysis with all samples including the amended effect sizes (white points).